Biontech to hold digital press conference to provide an update on omicron variant

Mainz, germany, december 8, 2021 – biontech se (nasdaq: bntx, “biontech” or “the company”) will hold a digital press conference on wednesday, december 8, 2021, to present the results from initial laboratory studies which started about two weeks ago. the studies aimed to investigate the effects of the omicron variant on covid-19 vaccine-induced immune responses. the press conference will solely be held in a virtual format and will be conducted in english.
BNTX Ratings Summary
BNTX Quant Ranking